Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Jun Liu

Dr Jun Liu

Jun Liu



Starting September 2021, Jun worked as a Novo Nordisk Research Fellow alongside Professor Cornelia van Duijn (NDPH) and Dr Joanna Howson (Novo Nordisk Research Centre Oxford).

The project, "An Integrative Cross-omics Study of Non-Alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis," has led her to explore omics profiles and identify potential drug targets for NAFLD using proteomics, alongside integrating additional omics data.

Jun completed her clinical medicine degree at Shanghai Jiao Tong University in China in 2013 and gained experience in the clinical epidemiology of type 2 diabetes through a one-year research placement at Rui-Jin Hospital's Department of Endocrine and Metabolic Diseases in Shanghai.

She then advanced with an MSc in genetic epidemiology from the Erasmus Medical Center in Rotterdam, Netherlands. Jun's academic journey continued, culminating in a PhD on "Integration of Multi-Omics in Type 2 Diabetes and Related Disorders Research."

In 2019, Jun relocated to Oxford to join Oxford Population Health as a postdoctoral researcher, focusing on multi-omics data integration for cardiometabolic and neurological disorders. In 2023, she achieved full registration with the General Medical Council (GMC) in the UK.